This partnership with IMPAC will afford Siemens customers access to IMPAC’s latest innovative oncology information system (OIS) in addition to the radiation therapy systems from Siemens.
Moreover, Siemens and IMPAC will work together to develop interfaces between MOSAIQ and IONTRIS, making it possible to use MOSAIQ with Siemens particle therapy solutions in the future. Under the extended agreement, Siemens will offer the MOSAIQ software as its next generation OIS offering to LANTIS, the OIS currently sold by Siemens. Siemens LANTIS customers will have the option of upgrading to MOSAIQ or continuing to utilize their LANTIS systems. Siemens will extend service support and application training for its customers to include MOSAIQ.
MOSAIQ is an image-enabled electronic medical record for oncology that allows documentation of patient data, from diagnosis to therapy. Clinical images, lab results, and external documents can also be integrated. Support for additional business functions such as scheduling, invoicing, management reporting and analysis, among others, can also be implemented. "We have maintained a very successful partnership with IMPAC since 1992 in the area of oncology information systems. In addition to cooperating on the development of interfaces for our systems for photon and electron radiation therapy, we are now working together in particle therapy. We are confident we will be able to offer our customers sustainable oncology systems which help them to optimize workflows and master the daily challenges of the hospital routine," said Holger Schmidt, CEO Oncology Care Systems, Siemens Healthcare.
"We are pleased to partner with Siemens and look forward to continuing a long and mutually beneficial relationship. We are certain MOSAIQ will assist clinicians to efficiently manage even the most demanding workflows in oncology enabling our customers to deliver the best possible patient care," said Jay Hoey, IMPAC President and CEO.
About IMPAC Medical Systems, Inc. IMPAC Medical Systems, Inc., part of the Elekta Group, provides software solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as systems for anatomic pathology, clinical laboratory and cancer registry. With products that cover diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency and quality patient care. The Elekta Group provides oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders. With more than 2,500 employees globally, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros.
3-D visualization of the pancreas -- new tool in diabetes research
15.03.2017 | Umea University
New PET radiotracer identifies inflammation in life-threatening atherosclerosis
02.03.2017 | Society of Nuclear Medicine
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
23.03.2017 | Life Sciences
23.03.2017 | Power and Electrical Engineering
23.03.2017 | Earth Sciences